Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (28)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Najjam, S.
Right arrow Articles by Rider, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Najjam, S.
Right arrow Articles by Rider, C. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Glycobiology, Vol 8, 509-516, Copyright © 1998 by Society for Glycobiology

ORIGINAL ARTICLES

Further characterization of the binding of human recombinant interleukin 2 to heparin and identification of putative binding sites

S Najjam, B Mulloy, J Theze, M Gordon, R Gibbs and CC Rider
Division of Biochemistry, Royal Holloway University of London, Surrey, UK.

We have previously provided compelling evidence that human recombinant interleukin 2 (IL-2) binds to the sulfated polysaccharides heparin, highly sulfated heparan sulfate and fucoidan. Here we show that IL-2 binding is dependent on heparin chain length, but with fragments as small as 15-mers retaining binding activity. The addition of exogenous heparin has no effect on the in vitro biological activity of IL-2. In addition soluble IL-2 receptor alpha and beta polypeptides do not compete with heparin for the binding of IL-2. IL-2 bound by heparin is still recognized by two IL-2 specific monoclonal antibodies, 3H9 and H2- 8, whose epitopes lie in the amino terminal region. Murine IL-2 unlike its human counterpart fails to bind to heparin. Human IL-2 analogs with single amino acid substitutions at positions Lys43, Thr51, and Gln126 analogs no longer bind to heparin. By contrast the Arg38Ala analog retains heparin full heparin binding activity. These experimental findings together with molecular modeling studies suggest two putative heparin binding sites on human IL-2, one involving four basic residues, Lys48, Lys49, Lys54, and His55, and the other being a discontinuous site comprising Lys43, Lys64, Arg81, and Arg83. Neither of these two clusters is completely conserved in murine IL-2. Overall our data suggest that the binding of human IL-2 to heparin and heparan sulfate does not interfere with IL-2/IL-2 receptor interactions. Therefore, binding to glycosaminoglycan may be a mechanism for retaining the cytokine in an active form close to its site of secretion in the tissue, thus favoring a paracrine role for IL-2.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
R. T. Trifonova, G. F. Doncel, and R. N. Fichorova
Polyanionic Microbicides Modify Toll-Like Receptor-Mediated Cervicovaginal Immune Responses
Antimicrob. Agents Chemother., April 1, 2009; 53(4): 1490 - 1500.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Hayashida, Y. Chen, A. H. Bartlett, and P. W. Park
Syndecan-1 Is an in Vivo Suppressor of Gram-positive Toxic Shock
J. Biol. Chem., July 18, 2008; 283(29): 19895 - 19903.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
G. Helguera, J. A. Rodriguez, and M. L. Penichet
Cytokines fused to antibodies and their combinations as therapeutic agents against different peritoneal HER2/neu expressing tumors.
Mol. Cancer Ther., April 1, 2006; 5(4): 1029 - 1040.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
S. M. Rickard, R. S. Mummery, B. Mulloy, and C. C. Rider
The binding of human glial cell line-derived neurotrophic factor to heparin and heparan sulfate: importance of 2-O-sulfate groups and effect on its interaction with its receptor, GFR{alpha}1
Glycobiology, June 1, 2003; 13(6): 419 - 426.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. E. Wrenshall, J. L. Platt, E. T. Stevens, T. N. Wight, and J. D. Miller
Propagation and Control of T Cell Responses by Heparan Sulfate-Bound IL-2
J. Immunol., June 1, 2003; 170(11): 5470 - 5474.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Nardelli, L. Zaritskaya, M. Semenuk, Y. H. Cho, D. W. LaFleur, D. Shah, S. Ullrich, G. Girolomoni, C. Albanesi, and P. A. Moore
Regulatory Effect of IFN-{kappa}, A Novel Type I IFN, On Cytokine Production by Cells of the Innate Immune System
J. Immunol., November 1, 2002; 169(9): 4822 - 4830.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. S. Mummery and C. C. Rider
Characterization of the Heparin-Binding Properties of IL-6
J. Immunol., November 15, 2000; 165(10): 5671 - 5679.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
B. Mulloy and M. J. Forster
Conformation and dynamics of heparin and heparan sulfate
Glycobiology, November 1, 2000; 10(11): 1147 - 1156.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Salek-Ardakani, J. R. Arrand, D. Shaw, and M. Mackett
Heparin and heparan sulfate bind interleukin-10 and modulate its activity
Blood, September 1, 2000; 96(5): 1879 - 1888.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. E. Wrenshall and J. L. Platt
Regulation of T Cell Homeostasis by Heparan Sulfate-Bound IL-2
J. Immunol., October 1, 1999; 163(7): 3793 - 3800.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Hasan, S. Najjam, M. Y. Gordon, R. V. Gibbs, and C. C. Rider
IL-12 Is a Heparin-Binding Cytokine
J. Immunol., January 15, 1999; 162(2): 1064 - 1070.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Alkhalil, R. N. Achur, M. Valiyaveettil, C. F. Ockenhouse, and D. C. Gowda
Structural Requirements for the Adherence of Plasmodium falciparum-infected Erythrocytes to Chondroitin Sulfate Proteoglycans of Human Placenta
J. Biol. Chem., December 15, 2000; 275(51): 40357 - 40364.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Fukushima and K. Yamashita
Interleukin-2 Carbohydrate Recognition Modulates CTLL-2 Cell Proliferation
J. Biol. Chem., March 2, 2001; 276(10): 7351 - 7356.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.